Study of Anlotinib as the Maintenance Therapy for Extensive-stage Small Cell Lung Cancer

NCT03781869 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

116

Enrollment

OTHER

Sponsor class

Conditions

Extensive-stage Small Cell Lung Cancer

Interventions

DRUG: Anlotinib Hydrochloride; etoposide and cisplatin
DRUG: etoposide and cisplatin

Sponsor

Third Military Medical University